Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals

European Journal of Clinical Nutrition

Volumn 66, Issue 9, 2012, Pages 1035-1038

  Xia, C ^a   Li, R ^a   Zhang, S ^a   Gong, L ^a   Ren, W ^a   Wang, Z ^a   Li, Q ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

HOMA IR; insulin resistance; lipid accumulation index; obesity

Indexed keywords

CHOLESTEROL ESTER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID ACCUMULATION PRODUCT; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHINA; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84865997134     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.83     Document Type: Article

References (26)

1. Kriketos AD, Furler SM, Gan SK, Poynten AM, Chisholm DJ, Campbell LV. Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. J Clin Endocrinol Metab 2003; 88: 793-798. (Pubitemid 36207824)
2. Despré s JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-1049.
3. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin Norht Am 2008; 37: 635-646.
4. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007; 120(2 Suppl.1): S3-S8. (Pubitemid 46216205)
5. Scaglione R, Di Chiara T, Cariello T, Licata G. Visceral obesity and metabolic syndrome: two faces of the same medal? Intern Emerg Med 2010; 5: 111-119.
6. Lewanczuk RZ, Paty BW, Toth EL. Comparison of the [13C] glucose breath test to the hyperinsulinemic-euglycemic clampwhen determining insulin resistance. Diabetes Care 2004; 27: 441-447. (Pubitemid 38174069)
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
8. Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010; 9: 45.
9. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayma S et al. Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis 2011; 10: 79.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
11. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003; 52: 172-179. (Pubitemid 36042123)
12. Kahn HS. The 'lipid accumulation product' performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005; 5: 26.
13. Wiltgen D, Benedetto IG, Mastella LS, Spirtzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009; 24: 1726-1731.
14. Taverna MJ, Martinez-Larrad MT, Frechtel GD, Serrano-Rios M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 2011; 164: 559-567.
15. Ran XW, Li XS, Tong NW, Li QF, Tang BD, Li JX. Body fat distribution: its characteristic and relationship to cardiovascular risk factors in obese Chinese. J Sichuan Univ (Med Sci Edi) 2004; 35: 699-703 (in Chinese).
16. Bressler P, Bailey S, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia 1996; 39: 1345-1350. (Pubitemid 26356065)
17. Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab 2011; 22: 353-363.
18. Sam S, Haffner S, Davidson MH, D0Agostino Sr RB, Feinstein S, Kondos G et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care 2009; 32: 1916-1920.
19. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184. (Pubitemid 30451774)
20. St-Pierre J, Lemieux I, Vohl M, Perron P, Tremblay G, Despres J et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardio 2002; l90: 15-18. (Pubitemid 34671195)
21. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynold RF et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405. (Pubitemid 40523734)
22. Gu D, Reynolds K, Yang W, Chenn Wu X, Duan X et al. The prevalence of metabolic syndrome in the general adult population aged 35-74 years in China. Chin J Diabetes 2005; 13: 181-186.
23. Despré s JP, Cartier A, Cô té M, Arsenault BJ. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Ann Med 2008; 40: 514-523.
24. Kraegen EW, Cooney GJ, Ye J. Thompson. Triglycerides, fatty acids and insulin resistance-hyperinsulinemia. Exp Clin Endocrinol Diabetes, 2001; 109: S516-S526. (Pubitemid 32577694)
25. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 2001; 98: 7522-7527. (Pubitemid 32567981)
26. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes. Diabetes Care 2006; 29: 151-153. (Pubitemid 44033451)